Patients are still getting too many opioids to treat their acute pain because of inconsistent prescribing guidelines despite a push to significantly lower pain pill prescribing in the U.S., an FDA-sponsored report released Dec. 19 found.
Acute pain is one that a patient feels for no longer than 90 days. Although there’s a bevy of opioid prescribing guidelines floating around, the National Academies of Sciences, Engineering, and Medicine found a lot of them don’t have rigorous evidence to back them up. That’s an issue the federal government has tried to rectify in the last few years, but there’s still a ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.